课题基金 / 基金详情

Syntheses of Novel Biologically Active Compounds Utilizing Countesactive Action in diving Body and their Clinical Trials

Syntheses of Novel Biologically Active Compounds Utilizing Countesactive Action in diving Body and their Clinical Trials
利用潜水体内反作用的新型生物活性化合物的合成及其临床试验
批准号:
13672379
负责人:
SUZUKI Toshio
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SUZUKI Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Novel steroids, hemisuccinyl methyl glycolates were prepared from the corresponding methyl glycolates derived from predonisolone and dexamethasone based on a concept of the antedrug. Their topical anti-inflammatory activity was evaluated through croton-induced ear edema and paper disk granuloma bioassay. Two (20S)-succinyl dexamethasone derivatives indicated more potent anti-inflammatory activity than the parent compounds and did not show corticosteroidal side effects of thymic, adrenal involution or body weight loss due to easy conversion of the succinyl derivatives into active compounds followed by rapid elimination from the circulation system in the rat. From these results, these two derivatives might be candidates as the novel steroids without the systemic side effects of corticosteroids.On the other hand, we tried to isolate the neutralizing human antibody against verotoxin (VT), which is an enterotoxin produced from Escherichia coli, O157-H7. We constructed human antibody combinatorial library from PBL of the O157-postinfected donor. We selected three VT1-reactive rFab clones and two VT2-reactive rFab clones from the antibody combinatorial antibody panning against VTs. These clones were found to be cross-reactive with another type of VT, and showed no neutralizing activity against VTs. These results suggest that isolated clones would recognize the neutralization-unrelated epitope commonly presented in both VT1 and VT2.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Toshio Suzuki: "Synthesis and Fate of Novel steroids, Hemisuccinyl Meth of Glycolates Based on the Concept of Antedeag"(submitted).
Toshio Suzuki:“基于Antedeag概念的新型类固醇、乙醇酸半琥珀酰甲基的合成和命运”(已提交)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kyoji Okada: "Enhanced Antitumor Effect of Ultrasound in the presence of Piroxicam in a Muse Air Pouch Model"Jpn. J. Cancer Res. 93. 216-222 (2002)
Kyoji Okada:“在 Muse 气囊模型中存在吡罗昔康的情况下增强超声波的抗肿瘤作用”Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itoh K, Suzuki T, et al.: "Different binding property verotoxin-1 and verotoxin-2 against their qlycolipid receptor globotriaosylceramide"Tohoku J, Exp, Med. (in press). (2002)
Itoh K、Suzuki T 等人:“verotoxin-1 和 verotoxin-2 对其 Qlycolipid 受体 globotriaosylceramide 的不同结合特性”Tohoku J,Exp,Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toshio Suzuki: "Synthesis and Fate of Novel Steroid, Hemisuccinyl Methyl glycolates Based on the Concept of Antedrug"submitted.
Toshio Suzuki:“基于Antedrug概念的新型类固醇半琥珀酰甲基乙醇酸酯的合成和命运”提交。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Evaluation of electron-capture and beta-decay rates at stellar environments and nucleosynthesis
    • 批准号:
      19K03855
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2019
    • 负责人:
      SUZUKI Toshio
    • 依托单位:
    Development of Stereoselective Construction of Fused Polycyclic Skeletons Containing Quaternary Asymmetric Carbon and Application to Synthetic Studies of Natural Products
    • 批准号:
      17K05857
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2017
    • 负责人:
      SUZUKI Toshio
    • 依托单位:
    Lehman Brothers and Financial Crisis - from a viewpoint of the development of Investment Banking
    Constrained extremal problems on the search cost of Boolean values: Developing a method based on the capital-risk ratio
    • 批准号:
      16K05255
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2016
    • 负责人:
      SUZUKI Toshio
    • 依托单位:
    海外基金